Susan D. De Vore is Director of Elevance Health, Inc.. Currently has a direct ownership of 3,502 shares of ELV, which is worth approximately $1.13 Million. The most recent transaction as insider was on Aug 19, 2025, when has been sold 1,200 shares (Common Stock) at a price of $312.15 per share, resulting in proceeds of $374,580. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.5K
52.13% 3M change
105.88% 12M change
Total Value Held $1.13 Million

Susan D. DeVore Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 19 2025
BUY
Open market or private purchase
$374,580 $312.15 p/Share
1,200 Added 25.52%
3,502 Common Stock
May 14 2025
BUY
Grant, award, or other acquisition
-
601 Added 20.7%
2,302 Common Stock
May 15 2024
BUY
Grant, award, or other acquisition
-
388 Added 18.57%
1,701 Common Stock
May 10 2023
BUY
Grant, award, or other acquisition
-
457 Added 25.82%
1,313 Common Stock
May 18 2022
BUY
Grant, award, or other acquisition
-
440 Added 33.95%
856 Common Stock
Sep 01 2021
BUY
Grant, award, or other acquisition
-
416 Added 50.0%
416 Common Stock

Also insider at

UNM
Unum Group Financial Services
SOLV
Solventum Corp
SDD

Susan D. De Vore

Director
Chattanooga, TN

Track Institutional and Insider Activities on ELV

Follow Elevance Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELV shares.

Notify only if

Insider Trading

Get notified when an Elevance Health, Inc. insider buys or sells ELV shares.

Notify only if

News

Receive news related to Elevance Health, Inc.

Track Activities on ELV